Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Infliximab
1
Tumor necrosis factor-α inhibition restores matrix formation by human adipose-derived stem cells in the late stage of chondrogenic differentiation
11/25/2022 11:36:34 AM |
Browse: 252 |
Download: 558
2
Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease
8/10/2022 8:23:14 AM |
Browse: 349 |
Download: 1257
3
How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study
7/27/2022 2:48:54 AM |
Browse: 309 |
Download: 733
4
Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis
6/17/2022 3:19:26 AM |
Browse: 301 |
Download: 1015
5
Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients
5/13/2022 8:46:12 AM |
Browse: 356 |
Download: 1003
6
Differential diagnosis and management of immune checkpoint inhibitor-induced colitis: A comprehensive review
12/29/2021 9:44:51 AM |
Browse: 336 |
Download: 520
7
Real-world data on the infliximab biosimilar CT-P13 (Remsima®) in inflammatory bowel disease
12/23/2021 2:14:14 PM |
Browse: 361 |
Download: 1453
8
Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of literature
11/22/2021 10:34:53 AM |
Browse: 386 |
Download: 769
9
Hemorrhagic pericardial effusion following treatment with infliximab: A case report and review of literature
8/31/2021 6:51:26 AM |
Browse: 351 |
Download: 378
10
Approach to medical therapy in perianal Crohn’s disease
7/6/2021 2:31:17 AM |
Browse: 375 |
Download: 502
11
Infliximab treatment of glycogenosis Ib with Crohn's -like enterocolitis: A case report
6/24/2021 7:26:33 AM |
Browse: 415 |
Download: 872
12
Maintenance treatment with infliximab for ulcerative ileitis after intestinal transplantation: A case report
6/24/2021 7:26:33 AM |
Browse: 366 |
Download: 985
13
Recalcitrant paradoxical pustular psoriasis induced by infliximab: Two case reports
5/11/2021 11:07:20 AM |
Browse: 341 |
Download: 717
14
Treatment of acute severe ulcerative colitis using accelerated infliximab regimen based on infliximab trough level: A case report
4/22/2021 12:14:43 PM |
Browse: 438 |
Download: 909
15
Crohn's disease with infliximab treatment complicated by rapidly progressing colorectal cancer: A case report
4/9/2021 8:11:26 AM |
Browse: 510 |
Download: 1081
16
Predictive value of biologic blood concentration on endoscopic inactivity in inflammatory bowel disease: A systematic review
3/3/2021 10:02:01 AM |
Browse: 574 |
Download: 1421
17
Infliximab is effective in the treatment of ulcerative colitis with dermatomyositis: A case report
12/14/2020 8:10:05 AM |
Browse: 684 |
Download: 1305
18
First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus
11/20/2020 4:04:17 AM |
Browse: 751 |
Download: 1617
19
Real-world cost-effectiveness associated with infliximab maintenance therapy for moderate to severe Crohn’s disease in China
11/6/2020 7:36:12 AM |
Browse: 602 |
Download: 1742
20
Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab: A stepwise, safety and patient-orientated process towards sustainability
9/24/2020 6:20:22 AM |
Browse: 721 |
Download: 1677
21
Management of pembrolizumab-induced steroid refractory mucositis with infliximab: A case report
9/22/2020 3:17:13 AM |
Browse: 641 |
Download: 1016
22
Severe steroid refractory gastritis induced by Nivolumab: A case report
4/28/2020 8:04:31 AM |
Browse: 821 |
Download: 1225
23
Optimized timing of using infliximab in perianal fistulizing Crohn's disease
4/14/2020 12:30:24 PM |
Browse: 694 |
Download: 1321
24
Crohn’s-like acute severe colitis associated with Hermansky-Pudlak syndrome: A case report
2/27/2019 4:11:15 AM |
Browse: 997 |
Download: 1314
25
Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report
1/21/2019 9:20:19 AM |
Browse: 932 |
Download: 1225
26
Biosimilars in paediatric inflammatory bowel disease
9/20/2018 2:33:54 AM |
Browse: 1078 |
Download: 1047
27
Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting
2/2/2018 8:28:46 AM |
Browse: 1009 |
Download: 1414
28
Defining and predicting deep remission in patients with perianal fistulizing Crohn’s disease on anti-tumor necrosis factor therapy
9/14/2017 3:13:08 AM |
Browse: 943 |
Download: 1107
29
Strategies for overcoming anti-tumor necrosis factor drug antibodies in inflammatory bowel disease: Case series and review of literature
8/1/2017 12:23:47 AM |
Browse: 1010 |
Download: 1494
30
Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study
6/14/2017 9:25:57 AM |
Browse: 1019 |
Download: 1890
31
Clinical and economic impact of infliximab one-hour infusion protocol in patients with inflammatory bowel diseases: A multicenter study
5/4/2017 8:16:34 AM |
Browse: 825 |
Download: 1199
32
Combination therapy for inflammatory bowel disease
5/4/2017 8:16:34 AM |
Browse: 1066 |
Download: 1439
33
Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis
3/19/2017 6:44:00 PM |
Browse: 1036 |
Download: 2134
34
Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
2/26/2017 6:20:00 PM |
Browse: 1116 |
Download: 2144
35
Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodies
1/5/2017 11:10:00 AM |
Browse: 917 |
Download: 1604
36
Infliximab does not increase colonic cancer risk associated to murine chronic colitis
11/26/2016 6:56:00 PM |
Browse: 1030 |
Download: 1821
37
Update on medical and surgical options for patients with acute severe ulcerative colitis: What is new?
9/25/2016 2:53:00 PM |
Browse: 1012 |
Download: 1418
38
Inflammatory bowel disease surgery in the biologic era
5/17/2016 12:43:00 PM |
Browse: 1035 |
Download: 1131
39
Post-operative abdominal complications in Crohn’s disease in the biological era: Systematic review and meta-analysis
3/20/2016 9:10:00 PM |
Browse: 964 |
Download: 1520
40
Histological healing after infliximab induction therapy in children with ulcerative colitis
9/28/2015 6:06:00 PM |
Browse: 1081 |
Download: 1815
41
Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases
6/29/2015 4:40:00 PM |
Browse: 1176 |
Download: 1950
42
Severe Henoch–Schönlein purpura with infliximab for ulcerative colitis
5/20/2015 5:01:00 PM |
Browse: 1015 |
Download: 1566
43
Weber-Christian disease with ileocolonic involvement successfully treated with infliximab
5/13/2015 10:38:00 AM |
Browse: 1003 |
Download: 1389
44
Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
4/27/2015 4:29:00 PM |
Browse: 1079 |
Download: 1266
45
Ipilimumab associated colitis: An IpiColitis case series at MedStar Georgetown University Hospital
4/15/2015 11:01:00 AM |
Browse: 1071 |
Download: 1412
46
Long-term outcome of infliximab combined with surgery for perianal fistulizing Crohn's disease
3/1/2015 11:51:00 AM |
Browse: 1114 |
Download: 1244
47
Significance of low level infliximab in the absence of anti-infliximab antibodies
2/11/2015 5:56:00 PM |
Browse: 1072 |
Download: 1408
48
Anti-tumour necrosis factor agent and liver injury: Literature review, recommendations for management
12/18/2014 5:08:00 PM |
Browse: 1208 |
Download: 1429
49
Management of acute severe ulcerative colitis
11/19/2014 10:25:00 AM |
Browse: 1121 |
Download: 1220
50
Steroid-refractory ulcerative colitis and associated primary sclerosing cholangitis treated with infliximab
9/16/2014 6:10:00 PM |
Browse: 1111 |
Download: 829
Page 1 of 2 ( 68 items )
<<
1
2
>>
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345